Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,597 across all filing types
Latest filing 2015-01-20 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. regarding the progress of a major asset restructuring. It mentions stock suspension due to the planning of a significant matter, ongoing due diligence, audit, and evaluation work by intermediaries, and references regulatory rules about major asset restructuring. The document is relatively short (933 characters) and primarily provides updates on the progress of the restructuring and stock suspension status. It does not contain detailed financial statements or comprehensive financial analysis. It is not a full report but a progress announcement related to a capital restructuring event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2015-01-20 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement about obtaining invention patent certificates, detailing patent numbers, names, application and authorization dates, and validity periods. It is a brief regulatory announcement about intellectual property achievements, not a financial report, management change, voting result, or any other specific financial filing. The document length is short (831 characters), and it does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2015-01-19 Chinese
国信证券股份有限公司关于公司定期现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "定期现场检查报告" (Periodic On-site Inspection Report) issued by Guosen Securities Co., Ltd. regarding Guangdong Taicheng Pharmaceutical Co., Ltd. It details the findings of an on-site inspection covering governance, internal control, information disclosure, use of raised funds, performance, and other important matters for the period from July 31, 2014 to December 31, 2014. The report includes detailed compliance checks, interviews, document reviews, and concludes with the sponsor's opinion on the company's governance and risk status. It is not a full annual or interim financial report, nor an earnings release or audit report. It is a standalone inspection report related to regulatory compliance and internal controls, which fits the definition of an Audit Report / Information (AR). The document length is over 5,000 characters and contains substantive content, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2014
2015-01-14 Chinese
关于重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a major asset restructuring by Guangdong Taicheng Pharmaceutical Co., Ltd. It mentions stock suspension due to the planned major asset restructuring, ongoing due diligence, audit, and evaluation work by intermediaries, and the continuation of stock suspension until the board approves and announces the restructuring plan. The document is a progress update on a major asset restructuring, not the actual restructuring plan or report. It is not a full financial report, earnings release, or regulatory certification. The content fits best under Capital/Financing Update (CAP) as it relates to significant financing and restructuring activities.
2015-01-13 Chinese
关于重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. regarding the progress of a major asset restructuring. It mentions stock suspension due to the planning of a significant matter, multiple progress announcements, ongoing due diligence, and the continuation of stock suspension until the board approves and announces the restructuring plan. The document is short (950 characters) and serves as a progress update on a capital restructuring event, not a full financial report or detailed merger filing. It fits best under Capital/Financing Update (CAP) as it relates to updates on a major asset restructuring and stock suspension due to financing/capital structure changes.
2015-01-06 Chinese
关于控股股东进行股票质押式回购交易的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding a stock pledge repurchase transaction by a controlling shareholder. It details the shareholder's pledge of shares as collateral for financing, including the number of shares, percentage of total shares, and the pledge term. There is no financial report, earnings data, or management discussion. The document is a specific capital/financing update about share pledge transactions, which fits the Capital/Financing Update (CAP) category.
2014-12-30 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.